About the Authors
- Per Björk
-
Affiliation Active Biotech AB, Lund, Sweden
- Anders Björk
-
Affiliation Active Biotech AB, Lund, Sweden
- Thomas Vogl
-
Affiliation Institute of Immunology, University of Münster, Münster, Germany
- Martin Stenström
-
Affiliation Immunology Group, Lund University, Lund, Sweden
- David Liberg
-
Affiliation Active Biotech AB, Lund, Sweden
- Anders Olsson
-
Affiliation Active Biotech AB, Lund, Sweden
- Johannes Roth
-
Affiliation Institute of Immunology, University of Münster, Münster, Germany
- Fredrik Ivars
-
Affiliation Immunology Group, Lund University, Lund, Sweden
- Tomas Leanderson
-
*To whom correspondence should be addressed. E-mail: tomas.leanderson@med.lu.se
Affiliations Active Biotech AB, Lund, Sweden , Immunology Group, Lund University, Lund, Sweden
Competing Interests
PB, AB, MS, DL, AO, and TL are employees of Active Biotech, which is developing quinolines for commercial purposes. FI has a research grant from Active Biotech.
Author Contributions
JR, FI, and TL conceived and designed the experiments. PB, MS, DL, AO, and FI performed the experiments. PB, AB, JR, FI, and TL analyzed the data. TV contributed reagents/materials/analysis tools. TL wrote the paper.